Previous close | 20.85 |
Open | 21.31 |
Bid | 18.95 x 100 |
Ask | 22.56 x 300 |
Day's range | 21.27 - 22.59 |
52-week range | 14.89 - 32.53 |
Volume | |
Avg. volume | 685,701 |
Market cap | 2.041B |
Beta (5Y monthly) | 1.07 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Rocket Pharmaceuticals (RCKT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Rocket Pharmaceuticals' (RCKT) first-quarter earnings beat estimates. Devoid of marketed drugs, the company did not report any revenues during the quarter.